Wire · opportunities
FDA Approves Implantica RefluxStop for GERD Treatment
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 25 August 2026 · Fusion42 review
The FDA granted premarket approval for Implantica's RefluxStop device for GERD treatment, opening the U.S. market following Johnson & Johnson's exit from non-U.S. markets for their competing device.
This Wire brief sits within Fusion42's coverage of Medtech, and 5 sources have reported it between 20 Aug 2026 and 25 Aug 2026.
◆ ◆ The Wire takeaway
You can now access the large U.S. GERD treatment market as Johnson & Johnson retreats from international competition. Prepare to engage key U.S. surgeons quickly to capitalise on this regulatory opening and establish an early foothold.
◆ Coverage
5 sources · first reported 20 Aug 2026 · latest 25 Aug 2026
◆ Related on Wire
◆ Topics